Evidence map›Paper›PMID 40696313›Full record

ArticleBMC complementary medicine and therapies2025

Korean medicine registry for allergic rhinitis in real-world settings (KOREA-R): a multicenter registry protocol.

Boram Lee, Gyu Tae Chang, Hyelim Lee, Sun Haeng Lee, Tae Hwan Kim, Mi Mi Ko, Sumin Seo, Bok-Nam Seo, Su Eun Lim, Mi Ju Son

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Boram LeeKorea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0003-1679-0644
Gyu Tae ChangDepartment of Korean Pediatrics, College of Korean Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-2465-3298
Hyelim LeeDepartment of Pediatrics, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0001-7477-9991
Sun Haeng LeeDepartment of Korean Pediatrics, College of Korean Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-9454-4126
Tae Hwan KimDepartment of Korean Pediatrics, College of Korean Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0002-0492-9530
Mi Mi KoKorea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0002-5758-4655
Sumin SeoKorea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0003-1892-8862
Bok-Nam SeoKorea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0002-0885-2078
Su Eun LimKorea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0001-6158-4845
Mi Ju SonKorea Institute of Oriental Medicine, Daejeon, Republic of Korea. mj714@kiom.re.kr.ORCID http://orcid.org/0000-0003-1701-9122

Funding

Korea Health Industry Development Institute RS-2024-00439613
6 · The paper itself

Abstract

backgroundAllergic rhinitis is a prevalent immune disorder with a significant impact on quality of life and socioeconomic burden. Korean Medicine treatments such as herbal medicine and acupuncture are widely utilized for allergic rhinitis due to clinical effectiveness and patient preferences. In particular, herbal decoctions, a key component of Korean Medicine treatment for allergic rhinitis, offer personalized treatment but pose challenges for randomized controlled trials due to the difficulty of placebo development. This study aims to establish a registry utilizing real-world data (RWD) on Korean Medicine treatment for allergic rhinitis, focusing on the effectiveness, safety, and cost-effectiveness of herbal decoctions in clinical practice.

methodsThe KOrean medicine REgistry for Allergic rhinitis in Real-world settings (KOREA-R) aims to enroll 400 patients with allergic rhinitis receiving Korean Medicine treatment at two Korean Medicine hospitals from February 2025 to June 2028. Patients will be examined in three visits at 2-week intervals, followed by two additional online follow-ups at 6 and 12 months after week 4. RWD on symptom severity, quality of life, treatment administration and compliance, adverse events, and laboratory blood tests will be collected. Participation is voluntary, with no restrictions on treatment types or dosages. Statistical analyses, including propensity score matching and difference-in-difference, will be used to evaluate the effectiveness, safety, and cost-effectiveness of Korean Medicine treatment, particularly herbal decoctions. Data management ensures confidentiality and quality through a validated electronic data capture system and regular monitoring.

conclusionThe findings of KOREA-R will provide insights into the effectiveness and safety of Korean Medicine treatment for allergic rhinitis, with a focus on herbal decoctions tailored to individual patient symptoms and pattern identifications. Additionally, by systematically collecting RWD for multidimensional analysis, KOREA-R will offer valuable information on the cost-utility and cost-effectiveness of herbal decoctions for both patients and healthcare policymakers. STUDY REGISTRATION: Clinical Research Information Service, KCT0010133 (Registration date: January 13, 2025).

Indexed as

Medicine, Korean TraditionalRegistriesRhinitis, AllergicAdultCost-Benefit AnalysisFemaleHumansMaleMulticenter Studies as TopicObservational Studies as TopicQuality of LifeRepublic of KoreaYoung AdultAllergic rhinitisHerbal DecoctionHerbal medicineKorean medicineRegistry

Identifiers

PMID40696313
PMCPMC12285187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.